Gastric ulcerations in COVID-19: an ominous sign?
Open Access
- 19 July 2021
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 14 (7) , e244059
Abstract
Gastrointestinal bleeding (GIB) is often reported in patients with COVID-19, with a reported incidence of 3% in a recent prospective cohort study of hospitalised patients with COVID-19. This study also reported that GIB is associated with an increase in mortality in patients with COVID-19.1 The most common causes of bleeding observed on esophagogastroduodenoscopy (EGD) were gastroduodenal ulceration1 and esophagitis.2 We present three cases of patients with COVID-19 who developed massive GIB from gastric ulcers during the course of their hospitalisation despite being on proton-pump inhibitor prophylaxis. All these three patients ultimately had a fatal outcome, thereby reiterating the poor prognosis associated with gastric ulceration. We briefly describe the clinical course and the associated EGD findings in these patients.Keywords
This publication has 3 references indexed in Scilit:
- Gastrointestinal bleeding in hospitalized COVID‐19 patients: a propensity score matched cohort studyJournal of Internal Medicine, 2020
- Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, ItalyClinical Gastroenterology and Hepatology, 2020
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19Journal of Thrombosis and Haemostasis, 2020